What are the dosing options for naltrexone (opioid receptor antagonist) for treating alcohol cravings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Naltrexone Dosing Options for Alcohol Cravings

The standard dosing regimen for naltrexone in treating alcohol cravings is 50 mg once daily, with an initial dose of 25 mg for the first 1-3 days followed by an increase to 50 mg daily for a treatment period of 3-6 months, and potentially up to 12 months in some cases. 1

Standard Oral Dosing Protocol

  • Initial dosing: 25 mg once daily for 1-3 days 2
  • Maintenance dosing: 50 mg once daily 1
  • Alternative dosing schedule: 100 mg on Mondays and Wednesdays, and 150 mg on Fridays 2
  • Treatment duration: 3-6 months typically, but can extend to 12 months 2

Long-Acting Injectable Option

  • Vivitrol: 380 mg intramuscular injection administered monthly 2
  • This formulation has been shown to reduce heavy drinking days by 25% compared to placebo 3
  • Particularly useful for patients with medication adherence concerns

Monitoring Requirements

  • Liver function tests: Obtain at baseline and every 3-6 months during treatment 2
  • Treatment response: Evaluate at 12 weeks; if patient has not achieved 5% weight loss (a surrogate marker for response), consider discontinuation 1

Efficacy Considerations

  • Naltrexone works by decreasing dopamine concentration in the brain and dampening activation of the reward pathway by alcohol 2
  • This mechanism reduces excessive drinking, decreases recurrence rates, and increases abstinence duration 2
  • Completion rates in clinical trials are significantly higher with naltrexone (44.8%) compared to placebo (25.9%) 4

Special Considerations and Precautions

  • Contraindication: Naltrexone is not recommended in patients with alcoholic liver disease due to risk of toxic liver injury 2
  • Opioid use: Patients must be opioid-free for 7-10 days before starting naltrexone to avoid precipitated withdrawal 1
  • Hepatic impairment: In patients with moderate to severe hepatic impairment, the total daily dose should not exceed 1 tablet daily 1
  • Procedures requiring opioids: Discontinue naltrexone before procedures that may require opioid analgesia 1

Alternative Dosing Options

  • High-dose naltrexone: Some research supports using 150 mg/day in patients with prominent alcohol cravings 5
    • This higher dose was found to be safe and well-tolerated in a small open-label study
    • Significantly reduced alcohol consumption but requires further controlled studies

Alternative Medications for Patients with Liver Disease

For patients with alcoholic liver disease where naltrexone is contraindicated:

  • Baclofen: First-line option for patients with alcoholic liver disease 2, 6

    • Has been specifically tested in patients with liver cirrhosis
    • Effectively maintains abstinence by reducing alcohol craving
  • Acamprosate: Alternative option with no hepatic metabolism 2

    • Dosage: 1,998 mg/day (666 mg three times daily) for patients ≥60 kg
    • Reduced by one-third for patients <60 kg
    • Treatment duration: 3-6 months

Practical Application

When initiating naltrexone therapy:

  1. Confirm patient is opioid-free for at least 7-10 days
  2. Start with 25 mg daily for 1-3 days to assess tolerability
  3. Increase to 50 mg daily maintenance dose
  4. Monitor liver function at baseline and every 3-6 months
  5. Evaluate treatment response at 12 weeks
  6. Continue treatment for 3-6 months if effective

Remember that naltrexone should be used as part of a comprehensive treatment program that includes psychosocial interventions for optimal outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Naltrexone for alcohol-dependent patients.

Irish journal of medical science, 2004

Guideline

Management of Alcohol Cravings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.